行为减肥治疗对纤维肌痛症状影响的一项初步研究。
A pilot study of the effects of behavioral weight loss treatment on fibromyalgia symptoms.
作者信息
Shapiro Jennifer R, Anderson Drew A, Danoff-Burg Sharon
机构信息
Department of Psychology, University at Albany, State University of New York, Albany, NY, USA.
出版信息
J Psychosom Res. 2005 Nov;59(5):275-82. doi: 10.1016/j.jpsychores.2005.06.081.
OBJECTIVE
Previous studies have found a relation between weight loss and pain severity in various chronic pain populations. However, there has been little research examining the relation between body mass index (BMI) and fibromyalgia syndrome (FMS). The purpose of this pilot study was to investigate the relationship between BMI and FMS symptoms and to determine if FMS symptoms would decrease following weight loss.
METHODS
Overweight and obese women participated in a 20-week behavioral weight loss treatment.
RESULTS
Participants, on average, lost 9.2 lbs (4.4% of their initial weight), and there were significant pre-postimprovements on several outcome measures. Although weight was not significantly related to pain at baseline, weight loss significantly predicted a reduction in FMS, pain interference, body satisfaction, and quality of life (QOL).
CONCLUSION
Findings suggest that behavioral weight loss treatment could be included in the treatment for overweight/obese women with FMS.
目的
先前的研究已经在各种慢性疼痛人群中发现体重减轻与疼痛严重程度之间存在关联。然而，很少有研究探讨体重指数（BMI）与纤维肌痛综合征（FMS）之间的关系。这项初步研究的目的是调查BMI与FMS症状之间的关系，并确定体重减轻后FMS症状是否会减轻。
方法
超重和肥胖女性参加了为期20周的行为减肥治疗。
结果
参与者平均减重9.2磅（占其初始体重的4.4%），并且在几项结局指标上前后有显著改善。尽管在基线时体重与疼痛没有显著相关性，但体重减轻显著预示着FMS、疼痛干扰、身体满意度和生活质量（QOL）的降低。
结论
研究结果表明，行为减肥治疗可以纳入超重/肥胖FMS女性的治疗中。
Zotero 插件